Ischemic Stroke, Lessons from the Past towards Effective Preclinical Models
Ischemic stroke is a leading cause of death worldwide, mainly in western countries. So far, approved therapies rely on reperfusion of the affected brain area, by intravenous thrombolysis or mechanical thrombectomy. The last approach constitutes a breakthrough in the field, by extending the therapeut...
Main Authors: | Beatriz Amado, Lúcia Melo, Raquel Pinto, Andrea Lobo, Pedro Barros, João R. Gomes |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/10/2561 |
Similar Items
-
Advanced bioengineering technologies for preclinical research
by: Elena Martinez, et al.
Published: (2019-01-01) -
Efficacy of Cerebrolysin Treatment as an Add-On Therapy to Mechanical Thrombectomy in Patients With Acute Ischemic Stroke Due to Large Vessel Occlusion: Study Protocol for a Prospective, Open Label, Single-Center Study With 12 Months of Follow-Up
by: Jacek Staszewski, et al.
Published: (2022-07-01) -
Sixth European Seminar in Virology on Virus–Host Interaction at Single Cell and Organism Level
by: Elisa Saccon, et al.
Published: (2018-07-01) -
Models of Herpes Simplex Virus Latency
by: Paige N. Canova, et al.
Published: (2024-05-01) -
A Review of the Advancements in the in-vitro Modelling of Acute Ischemic Stroke and Its Treatment
by: Sarah Johnson, et al.
Published: (2022-06-01)